BQST.US BioQuest Corp
- Market cap
- USD 7.47M
- P/E
- -
- P/B
- 0.35x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is BQST.US undervalued?
Graham numberThe Graham number of BioQuest Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
BioQuest Corp fundamental analysis
No fundamental analysis for BioQuest Corp yet.
BioQuest Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About BioQuest Corp
BioQuest Corp. develops and offers AI-powered solutions to help organizations automate communication, enhance engagement, and reduce operational costs. It serves a range of industries, including corporations, SMBs, nonprofits, government, education, athletics, entertainment, political campaigns, law enforcement, law firms, religious organizations, and public companies. The company is based in Katy, Texas.
Full company profileBioQuest Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
BioQuest Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | 0.00 | 0.00 | 0.00 | - | - | 144K | 179K | 98.4K |
| Gross Profit | -648.00 | - | - | -164.00 | -1.41K | -467.57 | - | - | 41.9K | 69.0K | 72.4K |
| Operating Income | -252K | -2.18K | -2.18K | -357K | -2.20M | -818K | -49.1K | -89.76 | -829K | -838K | -32.6K |
| EBITDA | -616K | -2.18K | -2.18K | -357K | -2.20M | -794K | -99.0K | -89.7K | -781K | -838K | -32.6K |
| Net Income | -616K | -2.18K | -2.18K | -362K | -2.36M | -721K | -141K | -123.00 | -781K | -905K | -84.2K |
| EPS | -23 | -0.02 | -0.02 | -0.09 | -0.29 | -0.07 | -0.01 | 0.00 | -0.07 | -0.03 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 890K | - | - | 166.00 | 17.1K | 33.5K | 31.00 | 5.91K | 1.11M | 1.65K | 3.81K |
| Total Liabilities | 14.7K | - | 8.82K | 139K | 1.79M | 467K | 554K | 633K | 910K | 1.00M | 1.13M |
| Shareholders' Equity | 875K | - | -8.82K | -139K | -1.77M | -433K | -554K | -627K | 202K | -1.10M | -1.12M |
| Cash & Short-term Investments | 544K | - | - | 166.00 | 260.00 | 33.5K | 31.00 | 5.91K | 2.08K | 1.65K | 3.81K |
| Total Debt | - | - | - | 40.0K | 74.2K | 183K | 183K | 183K | 388K | 384K | 388K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -600K | - | 2.18 | -125K | -193K | -117K | -53.5K | -62.7K | -746K | -300K | 73.6K |
| Capital Expenditure | 0.00 | - | 0.00 | 0.00 | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 0.00 |
| Free Cash Flow | -600K | - | 2.18 | -125K | -193K | -117K | -53.5K | -62.7K | -746K | -300K | 73.6K |
| Ratios | |||||||||||
| ROE | -70.4% | - | - | - | - | - | - | - | -387.4% | - | - |
| ROA | -69.2% | - | - | -217,773.5% | -13,812.9% | -2,150.9% | -453,754.8% | -2.1% | -70.3% | -54,785.4% | -2,211.2% |
| Net Profit Margin | - | - | - | - | - | - | - | - | -541.2% | -506.9% | -85.6% |
| Debt to Equity | - | - | - | - | - | - | - | - | 1.92x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
BioQuest Corp dividends
BioQuest Corp has not paid dividends in the last 9 fiscal years.
Last stock split: 1:2000 on Nov 15, 2019.
Who owns BioQuest Corp
- Insiders 88.67%
- Institutions 0.00%
- Public & others 11.33%
- Shares outstanding 29.9M
- Free float 1.30M
BioQuest Corp company profile
- Company name
- BioQuest Corp
- Ticker
- BQST.US
- Exchange
- USA Stocks
- Sector
- Technology
- Industry
- Pharmaceuticals
- Fiscal year end
- April
- Address
- 6725 South FRY Road, Katy, TX, United States, 77494
- Phone
- (714) 978-4425
- Website
- botmakers.ai
About BioQuest Corp
BioQuest Corp. develops and offers AI-powered solutions to help organizations automate communication, enhance engagement, and reduce operational costs. It serves a range of industries, including corporations, SMBs, nonprofits, government, education, athletics, entertainment, political campaigns, law enforcement, law firms, religious organizations, and public companies. The company is based in Katy, Texas.
BioQuest Corp management
2- Ms. Corinda Joanne MeltonPresident & Chairman of the Board · born 1957
- Mr. Trent T. DanielChief Executive Officer